VEGF-DΔNΔC mediated angiogenesis in skeletal muscles of diabetic WHHL rabbits

European Journal of Clinical Investigation

Volumn 40, Issue 5, 2010, Pages 422-432

  Roy, Himadri ^a   Bhardwaj, Shalini ^a   Babu, Mohan ^a   Lähteenvuo, Johanna E ^a   Ylä Herttuala, Seppo ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Angiogenesis; Diabetes; ENOS; Hypercholesterolaemia; VEGF D N C; VEGFR 2

Indexed keywords

ADENOVIRUS VECTOR; ANGIOPOIETIN; BETA GALACTOSIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NEUROPILIN 2; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 2; LIPID;

ANGIOGENESIS; ANGIOGENIC GENE THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY PERMEABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM CELL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; HYPERCHOLESTEROLEMIA; LIMB; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SKELETAL MUSCLE; STEM CELL; UPREGULATION; VIRAL GENE DELIVERY SYSTEM; ANIMAL; BLOOD; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG EFFECT; GENE TRANSFER; GLUCOSE BLOOD LEVEL; LACTOSE OPERON; METABOLISM; PHYSIOLOGY; RABBIT;

ANIMALS; BLOOD GLUCOSE; CAPILLARY PERMEABILITY; DIABETES MELLITUS; GENE TRANSFER TECHNIQUES; HYPERCHOLESTEROLEMIA; LAC OPERON; LIPIDS; MUSCLE, SKELETAL; RABBITS; VASCULAR ENDOTHELIAL GROWTH FACTOR D;

EID: 77951229383     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02285.x     Document Type: Article

References (39)

1. Meurice T, Bauters C, Vallet B, Corseaux D, van Belle E, Hamon M et al. bFGF restores endothelium-dependent responses of hypercholesterolemic rabbit thoracic aorta. Am J Physiol 1997 272 : H613 7.
2. Van Belle E, Rivard A, Chen D, Silver M, Bunting S, Ferrara N et al. Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines. Circulation 1997 96 : 2667 2674.
3. Duan J, Murohara T, Ikeda H, Katoh A, Shintani S, Sasaki K et al. Hypercholesterolemia inhibits angiogenesis in response to hindlimb ischemia: nitric oxide-dependent mechanism. Circulation 2000 102 : 370 376.
4. Abaci A, Òuzhan A, Kahraman S, Eryol NK, Unal S, Arinç H et al. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation 1999 99 : 2239 2242.
5. Srinivasan S, Hatley ME, Bolick DT, Palmer LA, Edelstein D, Brownlee M et al. Hyperglycaemia-induced superoxide production decreases eNOS expression via AP-1 activation in aortic endothelial cells. Diabetologia 2004 47 : 1727 1734.
6. Chen YH, Lin SJ, Lin FY, Wu TC, Tsao CR, Huang PH et al. High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. Diabetes 2007 56 : 1559 1568.
7. Loomans CJ, de Koning EJ, Staal FJ, Rookmaaker MB, Verseyden C, de Boer HC et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004 53 : 195 199.
8. Roy H, Bhardwaj S, Yla-Herttuala S. Biology of vascular endothelial growth factors. FEBS Lett 2006 580 : 2879 2887.
9. McColl BK, Stacker SA, Achen MG. Molecular regulation of the VEGF family - inducers of angiogenesis and lymphangiogenesis. APMIS 2004 112 : 463 480.
10. Kärpänen T, Heckman CA, Keskitalo S, Jeltsch M, Ollila H, Neufeld G et al. Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. FASEB J 2006 20 : 1462 1472.
11. Yla-Herttuala S, Martin JF. Cardiovascular gene therapy. Lancet 2000 355 : 213 222.
12. Mäkinen K, Manninen H, Hedman M, Matsi P, Mussalo H, Alhava E et al. Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study. Mol Ther 2002 6 : 127 133.
13. Rissanen TT, Markkanen JE, Gruchala M, Heikura T, Puranen A, Kettunen MI et al. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses. Circ Res 2003 92 : 1098 1106.
14. Bhardwaj S, Roy H, Gruchala M, Viita H, Kholova I, Kokina I et al. Angiogenic responses of vascular endothelial growth factors in periadventitial tissue. Hum Gene Ther 2003 14 : 1451 1462.
15. Roy H, Bhardwaj S, Babu M, Kokina I, Uotila S, Ahtialansaari T et al. VEGF-A, VEGF-D, VEGF receptor-1, VEGF receptor-2, NFkB and RAGE in atherosclerotic lesions of diabetic Watanabe Heritable Hyperlipidemic rabbits. FASEB J 2006 20 : 2159 2161.
16. Rissanen TT, Markkanen JE, Arve K, Rutanen J, Kettunen MI, Vajanto I et al. Fibroblast growth factor 4 induces vascular permeability, angiogenesis and arteriogenesis in a rabbit hindlimb ischemia model. FASEB J 2003 17 : 100 102.
17. Rissanen TT, Korpisalo P, Markkanen JE, Liimatainen T, Ordén MR, Kholová I et al. Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis. Circulation 2005 112 : 3937 3946.
18. Ylä-Herttuala S, Lipton BA, Rosenfeld ME, Särkioja T, Yoshimura T, Leonard EJ et al. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 1991 88 : 5252 5256.
19. Martin A, Komada MR, Sane DC. Abnormal angiogenesis in diabetes mellitus. Med Res Rev 2003 23 : 117 145.
20. Cudmore M, Ahmad S, Al-Ani B, Hewett P, Ahmed S, Ahmed A. VEGF-E activates endothelial nitric oxide synthase to induce angiogenesis via cGMP and PKG-independent pathways. Biochem Biophys Res Commun 2006 345 : 1275 1282.
21. Milkiewicz M, Hudlicka O, Brown MD, Silgram H. Nitric oxide, VEGF, and VEGFR-2: interactions in activity-induced angiogenesis in rat skeletal muscle. Am J Physiol Heart Circ Physiol 2005 289 : H336 43.
22. Staton CA, Kumar I, Reed MW, Brown NJ. Neuropilins in physiological and pathological angiogenesis. J Pathol 2007 212 : 237 248.
23. Belgore F, Blann A, Neil D, Ahmed AS, Lip GY. Localisation of members of the vascular endothelial growth factor (VEGF) family and their receptors in human atherosclerotic arteries. J Clin Pathol 2004 57 : 266 272.
24. Gallagher KA, Liu ZJ, Xiao M, Chen H, Goldstein LJ, Buerk DG et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest 2007 117 : 1249 1259.
25. Grunewald M, Avraham I, Dor Y, Bachar-Lustig E, Itin A, Jung S et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 2006 124 : 175 189.
26. Chavakis E, Urbich C, Dimmeler S. Homing and engraftment of progenitor cells: a prerequisite for cell therapy. J Mol Cell Cardiol 2008 45 : 514 522.
27. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000 95 : 952 958.
28. Murasawa S, Asahara T. Endothelial progenitor cells for vasculogenesis. Physiology 2005 20 : 36 42.
29. Li B, Sharpe EE, Maupin AB, Teleron AA, Pyle AL, Carmeliet P et al. VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J 2006 20 : 1495 1497.
30. Thum T, Fraccarollo D, Schultheiss M, Froese S, Galuppo P, Widder JD et al. Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes 2007 56 : 666 674.
31. Singh AK, Gudehithlu KP, Pegoraro AA, Singh GK, Basheerudin K, Robey RB et al. Vascular factors altered in glucose-treated mesangial cells and diabetic glomeruli. Changes in vascular factors impair endothelial cell growth and matrix. Lab Invest 2004 84 : 597 606.
32. Kämpfer H, Pfeilschifter J, Frank S. Expressional regulation of angiopoietin-1 and -2 and the tie-1 and -2 receptor tyrosine kinases during cutaneous wound healing: a comparative study of normal and impaired repair. Lab Invest 2001 81 : 361 373.
33. Mandriota SJ, Pepper MS. Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia. Circ Res 1998 83 : 852 859.
34. Oh H, Takagi H, Suzuma K, Otani A, Matsumura M, Honda Y. Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J Biol Chem 1999 274 : 15732 15739.
35. Park YS, Kim NH, Jo I. Hypoxia and vascular endothelial growth factor acutely up-regulate angiopoietin-1 and Tie2 mRNA in bovine retinal pericytes. Microvasc Res 2003 65 : 125 131.
36. Hangai M, Murata T, Miyawaki N, Spee C, Lim JI, He S et al. Angiopoietin-1 upregulation by vascular endothelial growth factor in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2001 42 : 1617 1625.
37. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S et al. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996 87 : 1171 1180.
38. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997 277 : 55 60.
39. Lund CO, Mortensen A, Nilas L, Breinholt VM, Larsen JJ, Ottesen B. Estrogen and phytoestrogens: effect on eNOS expression and in vitro vasodilation in cerebral arteries in ovariectomized Watanabe heritable hyperlipidemic rabbits. Eur J Obstet Gynecol Reprod Biol 2007 130 : 84 92.